economy
Eli Lilly Secures Long-Awaited FDA Approval for Its Obesity Pill. Here's What to Know
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.
TL;DR
- Stock markets rallied due to optimism surrounding a potential ceasefire in the Middle East.
- Eli Lilly's GLP-1 pill for obesity, Foundayo, received FDA approval and will be available through LillyDirect.
- Foundayo offers an oral alternative to injectable GLP-1s, potentially appealing to needle-adverse patients and serving as a maintenance therapy.
- DuPont sold its Aramids business (Kevlar, Nomex) to Arclin for $1.2 billion in cash, aiming to focus on healthcare acquisitions and faster-growing markets.
- Cybersecurity is considered a strong sector, with experts believing AI and LLMs will enhance rather than replace defensive systems.
- Upcoming economic data includes the monthly job cuts report and weekly jobless claims.